Search Results 2141-2150 of 20191 for Receptor

  1. restless legs Archives - Mayo Clinic News Network

    ... receptors in the brain, such as ropinirole, pramipexole or rotigotine, can help control RLS symptoms. Side effects of dopamine medications, however, may ...

  2. PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS - Mayo Clinic

    - Diagnosis of acute promyelocytic leukemia (APL M3): t(15;17)(q22;q12); (promyelocytic leukemia [PML]/retinoic acid receptor [RAR] alpha [a]) and variants ...

  3. Brain Tumor Program - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  4. Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer - Mayo Clinic

    No prior agents directed against epidermal growth factor-receptor; No other concurrent anticancer therapy. Participating Mayo Clinic locations. Study statuses ...

  5. A Study to Investigate Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache - Mayo Clinic

    Has previously received any CGRP ligand or receptor targeted monoclonal antibody. Eligibility last updated 1/19/22. Questions regarding updates should be ...

  6. A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism - Mayo Clinic

    Known activating mutation in the calcium-sensing receptor (CaSR) gene. 2. Impaired responsiveness to PTH (pseudohypoparathyroidism) which is characterized ...

  7. Doctors - Alzheimer's Disease Treatment Clinic

    ... receptor antibody encephalitis, Primary progressive aphasia, Posterior cortical atrophy, Autoimmune encephalitis, Wernicke-Korsakoff syndrome. Show more ...

  8. A Study To Evaluate The Safety And Effectiveness Of Bimagrumab On Improvement In Total Lean Body Mass And Physical Performance Following Surgical Treatment Of Hip Fracture. - Mayo Clinic

    ... receptors or the synthesis of these hormones within 3 months prior to randomization; Current use of high-dose selective beta2-adrenergic drug therapy; Ongoing ...

  9. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

    Group 1 (TP-0903 monotherapy): Patients with CLL/SLL who are intolerant to, or have progressed on B-cell receptor antagonists and/or BCL-2 antagonists; or ...

  10. Publications - Chad M. Ruoff, M.D. - Mayo Clinic

    Hypocretin receptor antagonists for insomnia: rationale and clinical data. Clinical Investigation. 2012; 2(6):623-37. Ruoff C, Cao M, Guilleminault C ...